Pub. Date : 2019 Jun
PMID : 30747308
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | UGT2B17 genotype was not associated with changes in BMD from 24 months of AI treatment, though in UGT2B17*2 homozygous patients, there was a trend toward greater decreases in BMD of the spine from treatment with letrozole compared with exemestane (P = 0.05). | Letrozole | UDP glucuronosyltransferase family 2 member B17 | Homo sapiens |